About this study

This study aims to examine the relationship between eye movements and driver behaviour to better understand the impact of medicinal cannabis use on driving performance in healthy adults under a variety of formulations, preparations, and doses of medicinal cannabis products available to patients.

It will also ensure that new vehicle safety technologies that are designed to detect and measure impairment due to substance usage are functioning in a way that is both accurate and reliable.

You may be eligible to participate if you:

  • are male or female aged 21 to 55 years  
  • are a regular driver (more than 4,000 kilometres per year) with three years of driving with a full driver’s licence (no 'P plate' drivers) 
  • are within the healthy BMI range (18.5 to >30). 
  • have previous (lifetime history) of cannabis use with no adverse side effects.


What’s involved?

Participants will be asked to attend four visits at Swinburne University for:

  • one screening session for a maximum of 1.5 hours
  • five testing sessions (one week apart) for a maximum of five hours each.

For further enquiries

Please email Brooke Manning at bmanning@swinburne.edu.au.

Our research ethics and integrity

Our researchers are committed to the highest ethical, professional and scholarly standards. All our studies conform to the Australian Code for the Responsible Conduct of Research, Good Clinical Practice and the National Statement on Ethical Conduct in Human Research.

Learn more

Explore more from our centre

Contact the Centre for Human Psychopharmacology

There are many ways to engage with us. If your organisation is dealing with a complex problem, get in touch to discuss how we can work together to provide solutions. Call us on +61 3 9214 4444 or email chp@swinburne.edu.au. 

Contact us